The company reported that Novartis wants to use one of its injectable drug delivery systems with...
AAIPharma Services, Corp. and Cambridge Major Laboratories, Inc. have announced the appointment...
Xcelience announced today the hiring of Joseph Iacobucci as Vice President of Clinical Supplies and Services. Mr. Iacobucci brings nearly 30 years of experience in clinical packaging and supply services, including 23 years as a Vice President for Clinical Systems, Inc.
Dutch chemicals maker Royal DSM NV has struck a deal to buy Canada's Patheon Inc. for $195 million (145 million euros), combine it with its own drug manufacturing operations, and spin them off into a new larger company.
Eurofins Lancaster Labs and Celsis International to Provide Rapid Micro Validation and Screening ServicesNovember 18, 2013 8:02 am | News | Comments
Eurofins Lancaster Laboratories and Celsis International Ltd. announced today that they have entered into a collaboration through which Eurofins Lancaster Laboratories will provide contract rapid microbiology validation and screening services for the Celsis rapid detection technology platform.
Bend Research Inc., part of Capsugel’s Dosage Form Solutions (DFS) business unit, announced today an investment of more than $20 million to expand commercial manufacturing for spray-dried dispersions at its facilities in Bend, Ore. The investment will encompass a facility expansion dedicated to commercial manufacturing with two new high-capacity PSD spray dryer process trains.
Hospira has unveiled a new quality and analytical testing laboratory at its Rocky Mount, N.C., plant in a ribbon-cutting ceremony attended by North Carolina Governor Pat McCrory and other local and state government leaders.
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, today announced that it has changed its name to Norwich Pharma Services.
Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories, based in San Antonio, Texas, and Confab, based in Saint-Hubert, Quebec, today announced the integration of the organizations under the leadership of Paul Johnson, Group President and COO.
AMRI today announced the appointment of Michael A. Luther, Ph.D., as Senior Vice President, Discovery, effective October 28, 2013. Dr. Luther will report to Thomas E. D'Ambra, Ph.D., President and CEO.Dr. Luther will lead AMRI's global discovery organization, which provides biology and chemistry services to the biopharmaceutical industry, with locations in the U.S., Singapore and Hyderabad, India.
Vetter, a contract development and manufacturing organization (CDMO), is investing more than $100 million across its production sites in Germany and the United States. Expanding and upgrading its facilities enable Vetter to meet increasing demand from its pharmaceutical and biotech customers for filling capacity, as well as keep pace with evolving regulatory requirements.
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has partnered with one of the world's leading pharmaceutical companies to develop a set of generic products. The collaboration is a new model of outsourcing that is designed to provide pharmaceutical companies with greater flexibility and support to maximize their investment in drug development.
Cambridge Major Laboratories, Inc., a provider of pharmaceutical API development and manufacturing, and AAIPharma Services Corp. a provider of pharmaceutical analytical testing, product development, and manufacturing services, have announced their intent to merge to form the premier global supplier of integrated CMC services.
Catalent's clinical-stage biologics facility is a critical part of the company's global capabilities.
Pharmaceutical Product Development, LLC ( PPD ) has appointed Gregory Dennis, M.D., as vice president of global product development. In this role, Dr. Dennis serves as therapeutic area head, providing medical and scientific expertise for rheumatology, immunology and inflammatory diseases.
Cedarburg Hauser Pharmaceuticals (CHP) announces the improvement of its Active Pharmaceutical Ingredient (API) plant in Grafton, WI. These upgrades are a continuation of a long-term capital improvement initiative that results from an increased demand for the contract manufacturing of commercial APIs.
Coldstream Laboratories, Inc., a provider of parenteral manufacturing and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development.
JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products, has entered into a manufacturing agreement with an undisclosed pharmaceutical company which has developed proprietary products that provide sustained and localized drug concentration. The agreement is for technical transfer, registration batch manufacture and commercial supply of a unique late stage ophthalmic product.
Theorem Clinical Research has announced the formation of a strategic alliance with Charles River Laboratories that will provide clients with an integrated solution from nonclinical testing and analysis through clinical development and registration.
Albany Molecular Research, Inc., a global contract research and manufacturing organization, announced that Thomas E. D'Ambra, Ph.D. will retire as President and Chief Executive Officer of the Company, effective December 31, 2013. Dr. D'Ambra will be named the company's non-executive Chairman of the Board of Directors on the same date.
The September 2013 issue of Pharmaceutical Processing features a profile of LSNE, a Bedford, NH-based contract manufacturing company that offers a range of lyophilization and fill/finish services. We also take a look at how CMOs are evaluating employee performance to improve operations, and our article on parenteral manufacturing services details some new trends for this important market segment.
The biopharmaceutical manufacturing industry today is enjoying a rebound in budgets, as the global financial crisis continues to recede. Despite positive signs, lessons learned from the economic crunch remain fresh, and continue to drive demand for cost-cutting and productivity.
New Hampshire-based LSNE offers right-sized fill/finish and lyophilization services that are tailored to client's needs and production requirements.
Quintiles has signed an agreement to acquire Novella Clinical, a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.
Pharmaceutical research contractor Parexel International Corp. reported a 69 percent leap in fiscal fourth-quarter earnings Wednesday, boosted by increased service revenue and lower operating costs. Parexel reported net income of $30 million, or 52 cents per share, up from $17.8 million, or 29 cents per share, in the 2012 fourth quarter.
Pharmaceutical Product Development, LLC today announced it has appointed David Johnston, Ph.D., as executive vice president of global laboratory services. Dr. Johnston directs PPD’s industry-leading, comprehensive laboratory services, including bioanalytical, vaccines and biologics, current good manufacturing practice (cGMP) and central laboratories.
Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that their 25 Commerce Drive, Bedford NH facility received a Certificate of GMP Compliance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture aseptic lyophilized drug products for use in the European Union.
- Page 1